PRL‑3 increases the aggressive phenotype of prostate cancer cells inï¿½vitro and its expression correlates with high-grade prostate tumors in patients-Reference-Cited by-同舟云学术

PRL‑3 increases the aggressive phenotype of prostate cancer cells inï¿½vitro and its expression correlates with high-grade prostate tumors in patients

Published:2017-11-20 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Edwards Donna¹,Moroz Krzysztof²,Zhang Haitao²,Mulholland David³,Abdel-Mageed Asim⁴,Mondal Debasis¹

Affiliation:

1. Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA 70112, USA

2. Department of Pathology, Tulane University School of Medicine, New Orleans, LA 70112, USA

3. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

4. Department of Urology, Tulane University School of Medicine, New Orleans, LA 70112, USA

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody;Molecular Therapy - Oncolytics;2023-09

2. A systematic method introduced a common lncRNA-miRNA-mRNA network in the different stages of prostate cancer;Frontiers in Oncology;2023-05-08

3. PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types;Theranostics;2023

4. LINC01207 promotes prostate cancer progression by sponging miR‑1182 to upregulate AKT3;Oncology Letters;2021-12-21

5. Expression, Localization, and Function of the Nucleolar Protein BOP1 in Prostate Cancer Progression;The American Journal of Pathology;2021-01